AstraZeneca

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.

About AZN

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company’s history roots back to the year 1913 when Astra business was formed.

CEO

Pascal Soriot

CEOPascal Soriot

Employees

94,300

Employees94,300

Headquarters

Cambridge, Cambridgeshire

HeadquartersCambridge, Cambridgeshire

Founded

1913

Founded1913

Employees

94,300

Employees94,300

AZN Key Statistics

Market cap

287.93B

Market cap287.93B

Price-Earnings ratio

30.51

Price-Earnings ratio30.51

Dividend yield

1.66%

Dividend yield1.66%

Average volume

11.92M

Average volume11.92M

High today

$93.51

High today$93.51

Low today

$92.46

Low today$92.46

Open price

$93.05

Open price$93.05

Volume

5.53M

Volume5.53M

52 Week high

$96.51

52 Week high$96.51

52 Week low

$61.24

52 Week low$61.24

AZN News

TipRanks 14h

AstraZeneca Advances AZD5148: Early Safety Data Strengthens Its Infectious Disease Pipeline

AstraZeneca (AZN) announced an update on their ongoing clinical study. Study Overview AstraZeneca is running a Phase I trial called “A Phase I Double-blind, P...

Benzinga 18h

AstraZeneca Expands Weight Loss Push With Eight-Program China Collaboration

On Friday, AstraZeneca Plc (NASDAQ:AZN) announced that it has strengthened its weight management portfolio through a new strategic collaboration agreement with...

The Wall Street Journal 18h

Health Care Roundup: Market Talk

Gonzalo Fuentes/Reuters The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET...

Analyst ratings

83%

of 30 ratings

Buy

83.3%

Hold

3.3%

Sell

13.3%

More AZN News

TipRanks 19h

AstraZeneca announces collaboration agreement with CSPC

AstraZeneca (AZN) announced that it is strengthening its weight management portfolio through a new strategic collaboration agreement with CSPC Pharmaceuticals (...

TipRanks 20h

AstraZeneca Moves Deeper into Weight Loss Market with New $18.5B CSPC Agreement

AstraZeneca (AZN) is making a major push into the fast-growing obesity drug market. The U.K. pharmaceutical giant has signed a collaboration and licensing deal...

The Wall Street Journal 22h

AstraZeneca Strikes Multibillion-Dollar Obesity Deal With China’s CSPC

The U.K. pharmaceutical company said CSPC would receive an upfront payment of $1.2 billion. yves herman/Reuters AstraZeneca AZN -0.36 %decrease; red down point...

TipRanks 23h

AstraZeneca Strikes $1.2bn CSPC Deal to Bolster Obesity Drug Portfolio

AstraZeneca ( (GB:AZN) ) just unveiled an update. AstraZeneca has entered a strategic collaboration with China’s CSPC Pharmaceuticals to expand its weight mana...

Benzinga 2d

AstraZeneca Bets Big On China With Massive $15 Billion Investment

AstraZeneca Plc (NASDAQ:AZN) on Thursday announced $15 billion investment in China through 2030 to expand medicines manufacturing and R&D. In July 2025, AstraZ...

TipRanks 2d

AstraZeneca plans to invest $15B in China through 2030

AstraZeneca (AZN) announced $15B investment in China through 2030 to expand medicines manufacturing and R&D. Pascal Soriot, Chief Executive Officer, AstraZeneca...

CNBC 3d

Airbus, AstraZeneca and HSBC executives join UK's Starmer on high-stakes China trip

BEIJING — Nearly 60 British businesses and cultural organizations will join U.K. Prime Minister Keir Starmer on his trip to China this week, the first such stat...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.